Recommended Dosing of Sumatriptan for Migraine Headaches in Adults
The recommended dose of oral sumatriptan for migraine headaches in adults is 25 mg, 50 mg, or 100 mg, with a maximum daily dose of 200 mg in a 24-hour period. 1
Oral Administration
- The FDA-approved dosing for oral sumatriptan is 25 mg, 50 mg, or 100 mg 1
- Doses of 50 mg and 100 mg may provide greater effect than 25 mg, but 100 mg may not provide greater effect than 50 mg 1
- If migraine has not resolved after 2 hours or returns after transient improvement, a second dose may be administered at least 2 hours after the first dose 1
- Maximum daily dose should not exceed 200 mg in a 24-hour period 1
- In patients with mild to moderate hepatic impairment, the maximum single dose should not exceed 50 mg 1
Alternative Routes of Administration
- Subcutaneous: 6 mg, which can be repeated after one hour, with a maximum daily dose of 12 mg per 24 hours 2
- Intranasal: 5-10 mg (one to two sprays) in one nostril, which can be repeated after 2 hours, with a maximum daily dose of 40 mg per day 2
Efficacy Considerations
- The 100 mg oral dose has shown better efficacy than 50 mg for pain-free and headache relief at two hours 3
- For headache relief at 2 hours, Numbers-Needed-to-Treat (NNTs) were 3.4,3.2, and 3.4 for sumatriptan 100 mg, 50 mg, and 25 mg, respectively 4
- Treating early during the mild pain phase provides better outcomes than treating established attacks with moderate or severe pain intensity 3
- Patients should try a medication for 2-3 headache episodes before abandoning that line of therapy 5
Combination Therapy
- If patients use an adequate dose of sumatriptan and still do not have sufficient pain relief, consider combining with an NSAID or acetaminophen 6
- Current guidelines recommend adding a triptan to an NSAID or acetaminophen when monotherapy does not provide sufficient pain relief 6
Important Contraindications
- Sumatriptan should not be used with ergotamine, MAOIs, or within 24 hours of another triptan 2
- Contraindicated in patients with hemiplegic or basilar migraine, pregnancy, impaired hepatic function, or coronary artery disease 2
Common Adverse Effects
- Adverse events are more common with sumatriptan 100 mg than with placebo 4
- Common side effects include nausea, warmth, vomiting, vertigo, malaise, headache, chest pressure and heaviness 5
- Subcutaneous administration can cause injection site reactions in approximately 30% of patients 2
- If the patient experiences unpleasant sensory disturbances with sumatriptan, trying a different triptan may be beneficial 5
Managing Treatment Failure
- If inadequate response after dose optimization, consider switching to another triptan (almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, or zolmitriptan) 6, 5
- Consider using a nonoral triptan and an antiemetic in people having severe nausea or vomiting 6
- Be aware that patients who do not tolerate or have inadequate response to a recommended migraine treatment may respond to another within the same drug class 6